Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-49,500
Closed -$5.21M 1873
2025
Q4
$5.21M Sell
49,500
-197,500
-80% -$18.5M 0.04% 509
2025
Q3
$20.7M Sell
247,000
-152,000
-38% -$12.5M 0.16% 139
2025
Q2
$31.6M Buy
399,000
+294,000
+280% +$23.4M 0.35% 49
2025
Q1
$9.42M Buy
+105,000
New +$9.8M 0.09% 220
2024
Q3
Sell
-70,000
Closed -$8.67M 1479
2024
Q2
$8.67M Hold
70,000
0.13% 168
2024
Q1
$9.24M Buy
+70,000
New +$8.63M 0.14% 183
2022
Q3
Sell
-79,900
Closed -$7.28M 1724
2022
Q2
$7.28M Buy
+79,900
New +$7.08M 0.1% 259
2022
Q1
Sell
-229,400
Closed -$17.6M 1755
2021
Q4
$17.6M Buy
229,400
+19,900
+9% +$1.59M 0.2% 119
2021
Q3
$15.7M Buy
209,500
+9,500
+5% +$723K 0.18% 141
2021
Q2
$15.6M Buy
+200,000
New +$14.9M 0.2% 109
2020
Q4
Sell
-104,800
Closed -$8.29M 1162
2020
Q3
$8.29M Sell
104,800
-104,800
-50% -$8.21M 0.19% 121
2020
Q2
$15.5M Buy
+209,600
New +$15.8M 0.52% 24
2019
Q2
Sell
-104,800
Closed -$8.32M 772
2019
Q1
$8.32M Buy
+104,800
New +$7.84M 0.46% 56

Other funds holding MRK

Caption Management's MRK Position: Q1 2026 in Review

Caption Management reduced its Merck (MRK) stake by 95% in Q1 2026, selling an estimated $13.9M and leaving 6,500 shares worth $782K. The position accounts for ﹤0.01% of the portfolio, ranked #1091.

Caption Management first reported a position in MRK in Q2 2021 and has held it in 9 quarters since. The position peaked at $18M in Q3 2021. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Caption Management held 6,500 shares of Merck worth $782K as of Q1 2026.
  • Caption Management sold 120,000 Merck shares in Q1 2026, an estimated $13.9M.
  • Merck made up ﹤0.01% of Caption Management's portfolio in Q1 2026, its #1091 holding.
  • Caption Management first reported a position in Merck in Q2 2021 and has held it in 9 quarters since.
  • Caption Management's Merck position peaked at $18M in Q3 2021.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.